STAT3 and breast carcinoma: A derivative of these compounds has been found to have a very high affinity to STAT3 SH2 (IC50 of 162 nM), and to inhibit the STAT3 phosphorylation, essential for its dimerization-dependent function(s), at 100 nM in MDA-MB-468 breast cancer cell line [123].